Skip to main content
Top
Published in: Systematic Reviews 1/2021

01-12-2021 | Hypoxic-Ischemic Brain Injury | Protocol

The clinical effects of cerebral near-infrared spectroscopy monitoring (NIRS) versus no monitoring: a protocol for a systematic review with meta-analysis and trial sequential analysis

Authors: Mathias Lühr Hansen, Simon Hyttel-Sørensen, Janus Christian Jakobsen, Christian Gluud, Elisabeth M. W. Kooi, Jonathan Mintzer, Willem P. de Boode, Monica Fumagalli, Ana Alarcon, Thomas Alderliesten, Gorm Greisen

Published in: Systematic Reviews | Issue 1/2021

Login to get access

Abstract

Background

Multiple clinical conditions are associated with cerebral hypoxia/ischaemia and thereby an increased risk of hypoxic-ischaemic brain injury. Cerebral near-infrared spectroscopy monitoring (NIRS) is a tool to monitor brain oxygenation and perfusion, and the clinical uptake of NIRS has expanded over recent years. Specifically, NIRS is used in the neonatal, paediatric, and adult perioperative and intensive care settings. However, the available literature suggests that clinical benefits and harms of cerebral NIRS monitoring are uncertain. As rates of clinically significant hypoxic-ischaemic brain injuries are typically low, it is difficult for randomised clinical trials to capture a sufficiently large number of events to evaluate the clinical effect of cerebral NIRS monitoring, when focusing on specific clinical settings. The aim of this systematic review will be to evaluate the benefits and harms of clinical care with access to cerebral NIRS monitoring versus clinical care without cerebral NIRS monitoring in children and adults across all clinical settings.

Methods

We will conduct a systematic review with meta-analysis and trial sequential analysis. We will only include randomised clinical trials. The primary outcomes are all-cause mortality, moderate or severe persistent cognitive or neurological deficit, and proportion of participants with one or more serious adverse events. We will search CENTRAL, EMBASE, MEDLINE, and the Science Citation Index Expanded from their inception and onwards. Two reviewers will independently screen all citations, full-text articles, and extract data. The risk of bias will be appraised using the Cochrane risk of bias tool version 2.0. If feasible, we will conduct both random-effects meta-analysis and fixed-effect meta-analysis of outcome data. Additional analysis will be conducted to explore the potential sources of heterogeneity (e.g. risk of bias, clinical setting).

Discussion

As we include trials across multiple clinical settings, there is an increased probability of reaching a sufficient information size. However, heterogeneity between the included trials may impair our ability to interpret results to specific clinical settings. In this situation, we may have to depend on subgroup analyses with inherent increased risks of type I and II errors.

Systematic review registration

PROSPERO CRD42020202986. This systematic review protocol has been submitted for registration in the International Prospective Register of Systematic Reviews (PROSPERO) (http://www.crd.york.ac.uk/prospero) on the 12th of October 2020 and published on the 12th of November 2020 (registration ID CRD42020202986).
Appendix
Available only for authorised users
Literature
4.
go back to reference Kluckow M. The pathophysiology of low systemic blood flow in the preterm infant. Front Pediatr. 2018;6:1–6.CrossRef Kluckow M. The pathophysiology of low systemic blood flow in the preterm infant. Front Pediatr. 2018;6:1–6.CrossRef
11.
23.
28.
go back to reference Oddo M, Taccone FS. How to monitor the brain in septic patients? Minerva Anestesiol. 2015;81(7):776–88.PubMed Oddo M, Taccone FS. How to monitor the brain in septic patients? Minerva Anestesiol. 2015;81(7):776–88.PubMed
31.
go back to reference Wood MD, Khan J, Lee KFH, Maslove DM, Muscedere J, Hunt M, et al. Assessing the relationship between near-infrared spectroscopy-derived regional cerebral oxygenation and neurological dysfunction in critically ill adults: a prospective observational multicentre protocol, on behalf of the Canadian Critical Care Trials Gro. BMJ Open. 2019;9(6):e029189. https://doi.org/10.1136/bmjopen-2019-029189.CrossRefPubMedPubMedCentral Wood MD, Khan J, Lee KFH, Maslove DM, Muscedere J, Hunt M, et al. Assessing the relationship between near-infrared spectroscopy-derived regional cerebral oxygenation and neurological dysfunction in critically ill adults: a prospective observational multicentre protocol, on behalf of the Canadian Critical Care Trials Gro. BMJ Open. 2019;9(6):e029189. https://​doi.​org/​10.​1136/​bmjopen-2019-029189.CrossRefPubMedPubMedCentral
39.
go back to reference Yu Y, Zhang K, Zhang L, Zong H, Meng L, Han R. Cerebral near-infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults. Cochrane Database Syst Rev. 2018:CD01947. Yu Y, Zhang K, Zhang L, Zong H, Meng L, Han R. Cerebral near-infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults. Cochrane Database Syst Rev. 2018:CD01947.
41.
go back to reference Huber W, Zanner R, Schneider G, Schmid R, Lahmer T. Assessment of regional perfusion and organ function: Less and non-invasive techniques. Front Med. 2019;6:1–15.CrossRef Huber W, Zanner R, Schneider G, Schmid R, Lahmer T. Assessment of regional perfusion and organ function: Less and non-invasive techniques. Front Med. 2019;6:1–15.CrossRef
44.
go back to reference Samsel RW, Schumacker PT. Oxygen delivery to tissues. Eur Respir J. 1991;4(10):1258–67.PubMed Samsel RW, Schumacker PT. Oxygen delivery to tissues. Eur Respir J. 1991;4(10):1258–67.PubMed
46.
go back to reference Chapman A, Meldrum B. Epileptic seizures and epilepsy. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, editors. Basic neurochemistry: molecular, cellular and medical aspects. 6th ed. Philadelphia: Lippincot-Raven; 1999. Chapman A, Meldrum B. Epileptic seizures and epilepsy. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, editors. Basic neurochemistry: molecular, cellular and medical aspects. 6th ed. Philadelphia: Lippincot-Raven; 1999.
50.
go back to reference Pellicer A, Greisen G, Benders M, Claris O, Dempsey E, Fumagally M, et al. The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. Neonatology. 2013;104(3):171–8. https://doi.org/10.1159/000351346.CrossRefPubMed Pellicer A, Greisen G, Benders M, Claris O, Dempsey E, Fumagally M, et al. The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. Neonatology. 2013;104(3):171–8. https://​doi.​org/​10.​1159/​000351346.CrossRefPubMed
52.
go back to reference Hyttel-Sørensen S, Pellicer A, Alderliesten T, Austin T, Van Bel F, Benders M, et al. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ. 2015;350:1–11.CrossRef Hyttel-Sørensen S, Pellicer A, Alderliesten T, Austin T, Van Bel F, Benders M, et al. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ. 2015;350:1–11.CrossRef
55.
go back to reference Hyttel-Sorensen S, Greisen G, Als-Nielsen B, Gluud C. Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants. Cochrane Database Syst Rev. 2017:CD011506. Hyttel-Sorensen S, Greisen G, Als-Nielsen B, Gluud C. Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants. Cochrane Database Syst Rev. 2017:CD011506.
63.
go back to reference Robertson GJ. Bayley Scales of Infant and Toddler Development. In: The Corsini encyclopedia of psychology Hoboken. NJ: John Wiley & Sons, Inc.; 2010.CrossRef Robertson GJ. Bayley Scales of Infant and Toddler Development. In: The Corsini encyclopedia of psychology Hoboken. NJ: John Wiley & Sons, Inc.; 2010.CrossRef
64.
go back to reference EMA/CHMP/ICH/135/1995. Guideline for good clinical practice E6 (R2). European Medicines Agency. 2016. available from: https://www.ema.europa.eu/en/ich-e6-r2-good-clinical-practice#current-version---revision-2-sectionweb site EMA/CHMP/ICH/135/1995. Guideline for good clinical practice E6 (R2). European Medicines Agency. 2016. available from: https://​www.​ema.​europa.​eu/​en/​ich-e6-r2-good-clinical-practice#current-version---revision-2-sectionweb site
65.
go back to reference Liberati A. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W-65–94.CrossRef Liberati A. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W-65–94.CrossRef
69.
go back to reference Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017 Feb 16;2:MR000033.PubMed Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017 Feb 16;2:MR000033.PubMed
74.
go back to reference Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.CrossRefPubMed Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.CrossRefPubMed
75.
go back to reference Higgins JP, Savović J, Page MJ, Elbers RG, Sterne JA. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions 6.1. Cochrane; 2020. Available from: www.training.cochrane.org/handbook. Higgins JP, Savović J, Page MJ, Elbers RG, Sterne JA. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions 6.1. Cochrane; 2020. Available from: www.​training.​cochrane.​org/​handbook.
78.
go back to reference Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ. 2012;344:1–11.CrossRef Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ. 2012;344:1–11.CrossRef
81.
go back to reference Deeks JJ, Higgins JP, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions 6.1. Cochrane; 2020. Available from: www.training.cochrane.org/handbook. Deeks JJ, Higgins JP, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions 6.1. Cochrane; 2020. Available from: www.​training.​cochrane.​org/​handbook.
90.
go back to reference Schünemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing “Summary of findings” tables and grading the certainty of the evidence. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions 6.1. Wiley; 2020. Available from: www.training.cochrane.org/handbook. Schünemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing “Summary of findings” tables and grading the certainty of the evidence. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions 6.1. Wiley; 2020. Available from: www.​training.​cochrane.​org/​handbook.
Metadata
Title
The clinical effects of cerebral near-infrared spectroscopy monitoring (NIRS) versus no monitoring: a protocol for a systematic review with meta-analysis and trial sequential analysis
Authors
Mathias Lühr Hansen
Simon Hyttel-Sørensen
Janus Christian Jakobsen
Christian Gluud
Elisabeth M. W. Kooi
Jonathan Mintzer
Willem P. de Boode
Monica Fumagalli
Ana Alarcon
Thomas Alderliesten
Gorm Greisen
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2021
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-021-01660-2

Other articles of this Issue 1/2021

Systematic Reviews 1/2021 Go to the issue